Arvee Laboratories (India) Ltd.

NSE:ARVEE.NS

173.59 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q1
Revenue 106.02261.43576.95489.10175.96241.087162.508227.381181.789120.26679.006106.99890.61989.585199.44895.45986.94693.22293.222133.872133.872116.819116.819157.691157.69186.845
Cost of Revenue 75.10835.8153.59751.04735.60566.04111.493136.453125.688107.03242.60762.63446.53472.211142.56555.68857.98626.67458.832103.095103.09594.2394.23121.806121.80656.217
Gross Profit 30.91425.62523.35738.05440.357-24.95351.01590.92856.10113.23436.39944.36444.08517.37456.88339.77128.9666.54834.3930.77730.77722.58922.58935.88535.88530.628
Gross Profit Ratio 0.2920.4170.3040.4270.531-0.6070.3140.40.3090.110.4610.4150.4860.1940.2850.4170.3330.7140.3690.230.230.1930.1930.2280.2280.353
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 000004.06500025.89200017.6810004.3724.372003.7223.722000
Selling & Marketing Expenses 000000.3130000.1690000.1410006.5566.7130010.19410.194000
SG&A 18.60921.38421.65422.389.6954.37818.20537.92924.38726.06211.55412.47220.28717.82115.311.94110.50713.76928.2436.8166.81620.23820.2387.3637.3636.068
Other Expenses 1.0642.0681.9270.9130.898-1.4760.6920.6160.234-2.4441.2250.7290.575-5.6131.2841.0730000000000
Operating Expenses 18.60921.38421.65435.33833.132-20.80837.7762.46439.7275.92528.86433.36635.83413.66835.36434.53821.34258.59726.43919.5219.5213.84413.84426.02926.02921.617
Operating Income 12.3054.2411.7033.636.3276.71313.24628.46516.3749.4927.53510.9988.2515.67421.5195.2334.2848.4448.44410.21810.2189.6059.6059.5159.5159.304
Operating Income Ratio 0.1160.0690.0220.0410.0830.1630.0820.1250.090.0790.0950.1030.0910.0630.1080.0550.0490.0910.0910.0760.0760.0820.0820.060.060.107
Total Other Income Expenses Net 0.2851.5491.476-0.8170.1860.022-0.939-1.091-1.1360.88-0.862-0.614-1.1890.614-1.074-2.2662.43-1.755-1.755-1.454-1.454-2.463-2.463-3.936-3.936-7.672
Income Before Tax 12.595.793.1792.8136.5136.73412.30727.37415.23810.3726.67310.3847.0626.28820.4452.9676.7146.6896.6898.7648.7647.1417.1415.585.581.632
Income Before Tax Ratio 0.1190.0940.0410.0320.0860.1640.0760.120.0840.0860.0840.0970.0780.070.1030.0310.0770.0720.0720.0650.0650.0610.0610.0350.0350.019
Income Tax Expense 3.1694.6290.80.7081.6396.6623.0976.8893.8352.5161.3343.1241.7771.9455.1460.861.691.161.882.4382.4380.1460.1461.5521.5520.311
Net Income 9.4211.162.3792.1054.8740.0939.20920.48411.4037.8565.3397.2595.2854.34415.2992.1075.0245.5294.8096.3266.3267.2877.2874.0284.0281.321
Net Income Ratio 0.0890.0190.0310.0240.0640.0020.0570.090.0630.0650.0680.0680.0580.0480.0770.0220.0580.0590.0520.0470.0470.0620.0620.0260.0260.015
EPS 0.850.110.220.190.440.0080.841.861.030.721.050.660.480.391.390.190.910.50.440.580.580.660.660.370.370.16
EPS Diluted 0.850.110.220.190.440.0080.841.861.030.721.050.660.480.391.390.190.910.50.440.580.580.660.660.370.370.16
EBITDA 15.3717.9715.2457.82610.73911.47618.10133.22922.79315.67211.317.6714.83911.82527.3711.279.98514.01114.01116.05316.05315.47914.99214.90214.90214.705
EBITDA Ratio 0.1450.130.0680.0880.1410.2790.1110.1460.1250.130.1430.1650.1640.1320.1370.1180.1150.150.150.120.120.1330.1280.0950.0950.169